2023

• West, S., Martin, A., Copping, R., Gard, G., Maher, R., Seeho, S. (2023). Staged treatment of placenta accreta spectrum: A combined surgical and radiological approach. Australian and New Zealand Journal of Obstetrics and Gynaecology, 63(3), 372-377. [More Information]

2021

• Obermair, H., Muir, G., Gard, G. (2021). Barriers to salpingectomy for permanent contraception: A qualitative study with obstetricians and gynaecologists. Australian and New Zealand Journal of Obstetrics and Gynaecology, 61(6), 973-977. [More Information]
• Stevens, M., West, S., Gard, G., Renaud, C., Nevell, D., Roderick, S., Le, A. (2021). Utility of adjuvant whole abdominal radiation therapy in ovarian clear cell cancer (OCCC): a pragmatic cohort study of women with classic immuno-phenotypic signature. Radiation Oncology, 16(1), 29. [More Information]

2018

• Shah, J., Gard, G., Yang, J., Maidens, J., Valmadre, S., Soon, P., Marsh, D. (2018). Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer. Gynecologic Oncology, 148(1), 181-188. [More Information]

2017

• Cole, A., Zhu, Y., Dwight, T., Yu, B., Dickson, K., Gard, G., Maidens, J., Valmadre, S., Gill, A., Clifton-Bligh, R., Marsh, D. (2017). Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency. Scientific Data, 4, 1-8. [More Information]
• Pickett, J., Chou, A., Andrici, J., Clarkson, A., Sioson, L., Sheen, A., Reagh, J., Najdawi, F., Kim, Y., Riley, D., Gard, G., Hogg, R., Turchini, J., Gill, A., et al (2017). Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required. American Journal of Surgical Pathology, 41(10), 1433-1442. [More Information]
• Najdawi, F., Crook, A., Maidens, J., McEvoy, C., Fellowes, A., Pickett, J., Ho, M., Nevell, D., Mcilroy, K., Sheen, A., Turchini, J., Hogg, R., Gard, G., Gill, A., et al (2017). Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. Pathology, 49(5), 457-464. [More Information]

2016

• Cole, A., Dwight, T., Gill, A., Dickson, K., Zhu, Y., Clarkson, A., Gard, G., Maidens, J., Valmadre, S., Clifton-Bligh, R., Marsh, D. (2016). Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing. Scientific Reports, 6, 1-12. [More Information]
• Dickson, K., Cole, A., Gill, A., Clarkson, A., Gard, G., Chou, A., Kennedy, C., Henderson, B., Fereday, S., Traficante, N., deFazio, A., Clifton-Bligh, R., Marsh, D., et al (2016). The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer. Human Molecular Genetics, 25(24), 5460-5471. [More Information]

2014

• Dixon, S., Ibiebele, T., Protani, M., Beesley, J., deFazio, A., Crandon, A., Gard, G., Rome, R., Webb, P., Nagle, C. (2014). Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival. Gynecologic Oncology, 132(3), 566-572. [More Information]

2012

• Kan, C., Hahn, M., Gard, G., Maidens, J., Huh, J., Marsh, D., Howell, V. (2012). Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. BMC Cancer, 12, 1-9. [More Information]

2010

• Angstmann, T., Gard, G., Harrington, T., Ward, E., Thomson, A., Giles, W. (2010). Surgical management of placenta accreta: a cohort series and suggested approach. American Journal of Obstetrics and Gynecology, 202(1), 38.e1-38.e9. [More Information]

2009

• Hirst, J., Gard, G., McIllroy, K., Nevell, D., Field, M. (2009). High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy. International Journal of Gynecological Cancer, 19(5), 826-829. [More Information]

2008

• Nippita, T., Maidens, J., Gard, G., Coyle, L. (2008). Prevention of premature menopause during gonadotoxic chemotherapy for haematological malignancy in young women. 12th Biennial Meeting of International Gynaecologic Cancer Society, Bangkok: International Gynecologic Cancer Society.